MEA Stroke Market - Industry Trends and Forecast to 2033

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $3,500	267 Pages	Data Bridge Market Research	October, 2023	DAABD18360531

Best Price Guarantee
Price	from $3,500
Length	267 Pages
Publisher	Data Bridge Market Research
Published Date	October, 2023
SKU	DAABD18360531

MEA Stroke Market - Industry Trends and Forecast to 2033

Middle East and Africa stroke market is projected to register a CAGR of 5.3% in the forecast period of 2023 to 2030. The new market report contains data for historic year 2021, the base year of calculation is 2022 and the forecast period is 2023 to 2030.
Market Segmentation:
Middle East and Africa Stroke Market, By Type (Ischemic Stroke, Transient Ischemic Attack (TIA) and Hemorrhage Stroke), Diagnosis (Imaging Test, Blood Test, Echocardiogram, Lumbar Puncture, and Other), Treatment (Medication, Other Therapy, and Surgery), Gender (Female and Male), End-User (Hospitals & Clinics, Specialty Clinics, Ambulatory Surgical Centers, Homecare, Laboratories and Others), Distribution Channel (Direct Tender, Retail Sales And Online Sales) Country (Saudi Arabia, UAE, South Africa, Egypt, Qatar, Kuwait, Oman, Bahrain and Rest of Middle East And Africa) – Industry trends and forecast to 2030.
Overview of Middle East and Africa Stroke Market Dynamics

Drivers
• Rising incidences of stroke
• Increasing number of patients with hypertension and coronary heart diseases

Restraints

• High cost associated with treatment of stroke
• Side-effects associated with medication

Opportunities

• Expansion of telemedicine and remote monitoring
• Innovative therapies in pipeline for stroke treatment
Market Players
Some of the major market players operating in the Middle East and Africa stroke market are:
• Bristol-Myers Squibb Company
• Boehringer Ingelheim International GmbH.
• F. Hoffmann-La Roche Ltd
• DAIICHI SANKYO COMPANY, LIMITED.
• Sanofi
• Johnson & Johnson Services, Inc.
• Bayer AG
• Sandoz AG
• Pfizer Inc.
• Medtronic
• Abbott
• Viatris Inc.
• AstraZeneca
• GLENMARK PHARMACEUTICALS LTD

1 Introduction: 1.1 Objectives Of The Study; 1.2 Market Definition; 1.3 Overview Of The Middle East And Africa Stroke Market; 1.4 Limitations; 1.5 Markets Covered
2 Market Segmentation: 2.1 Markets Covered; 2.2 Geographical Scope; 2.3 Years Considered For The Study; 2.4 Currency And Pricing; 2.5 Dbmr Tripod Data Validation Model; 2.6 Multivariate Modelling; 2.7 Type Lifeline Curve; 2.8 Primary Interviews With Key Opinion Leaders; 2.9 Dbmr Market Position Grid; 2.10 Market Application Coverage Grid; 2.11 Vendor Share Analysis; 2.12 Secondary Sources; 2.13 Assumptions
3 Executive Summary
4 Premium Insights: 4.1 Pestel's Model; 4.2 Porter's 5 Forces
5 Epidemiology
6 Middle East And Africa Stroke Market, Regulatory Framework: 6.1 Regulation In U.S; 6.2 Regulation In Europe; 6.3 Regulation In China; 6.4 Regulation In Japan; 6.5 Regulation In South Africa 7 Market Overview; 7.1 Drivers; 7.1.1 Rising Incidences Of Stroke; 7.1.2 Increasing Number Of Patients With Hypertension And Coronary Heart Diseases; 7.1.3 Increasing Diabetic And Obese Population; 7.1.4 Advancements In Medical Technology For Stroke Treatment; 7.2 Restraints; 7.2.1 High Cost Associated With Treatment Of Stroke; 7.2.2 Side-effects Associated With Medication; 7.3 Opportunities; 7.3.1 Expansion Of Telemedicine And Remote Monitoring; 7.3.2 Innovative Therapies In Pipeline For Stroke Treatment; 7.4 Challenges; 7.4.1 Inaccurate Diagnosis Of Strokes S; 7.4.2 Complications In Managing Stroke In Patients With Multiple Chronic Conditions
8 Middle East And Africa Stroke Market, By Type: 8.1 Overview; 8.2 Ischemic Stroke; 8.2.1 Thrombotic (Cerebral Thrombosis); 8.2.2 Embolic (Cerebral Embolism); 8.3 Hemorrhagic Stroke; 8.3.1 Subarachnoid Hemorrhage; 8.3.2 Intracerebral Hemorrhage; 8.4 Transient Ischemic Attack (Tia)
9 Middle East And Africa Stroke Market, By Treatment: 9.1 Overview; 9.2 Medication; 9.2.1 By Class; 9.2.1.1 Blood Pressure Medicines; 9.2.1.1.1 Angiotensin-converting Enzyme (Ace) Inhibitors; 9.2.1.1.1.1 Ramipril; 9.2.1.1.1.2 Lisinopril; 9.2.1.1.1.3 Enalapril; 9.2.1.1.1.4 Perindopril; 9.2.1.1.1.5 Other 9.2.1.1.2 Diuretics; 9.2.1.1.2.1 Indapamide; 9.2.1.1.2.2 Bendroflumethiazide; 9.2.1.1.2.3 Spironolactone; 9.2.1.1.2.4 Amiloride; 9.2.1.1.2.5 Other; 9.2.1.1.3 Calcium Channel Blockers; 9.2.1.1.3.1 Amlodipine; 9.2.1.1.3.2 Nifedipine; 9.2.1.1.3.3 Verapamil; 9.2.1.1.3.4 Nicardipine; 9.2.1.1.3.5 Felodipine; 9.2.1.1.3.6 Nimodipine; 9.2.1.1.3.7 Other; 9.2.1.1.4 Beta Blockers; 9.2.1.1.4.1 Atenolol; 9.2.1.1.4.2 Bisoprolol; 9.2.1.1.4.3 Labetolol; 9.2.1.1.4.4 Other; 9.2.1.1.5 Alpha Blockers; 9.2.1.1.5.1 Doxazosin; 9.2.1.1.5.2 Other; 9.2.1.1.6 Others; 9.2.1.1 Antiplatelet Drugs; 9.2.1.1.1 Aspirin; 9.2.1.1.2 Clopidogrel; 9.2.1.1.3 Dipyridamole; 9.2.1.1.4 Ticlopidine; 9.2.1.1.5 Others; 9.2.1.2 Anticoagulants; 9.2.1.2.1 Warfarin; 9.2.1.2.2 Apixaban; 9.2.1.2.3 Dabigatran; 9.2.1.2.4 Heparin; 9.2.1.2.5 Rivaroxaban; 9.2.1.2.6 Others; 9.2.1.3 Tissue Plasminogen Activator (Tpa); 9.2.1.3.1 Alteplase; 9.2.1.3.2 Tenecteplase; 9.2.1.3.3 Reteplase; 9.2.1.3.4 Anistreplase; 9.2.1.3.5 Others; 9.2.1.4 Statins; 9.2.1.4.1 Atorvastatin; 9.2.1.4.2 Simvastatin; 9.2.1.4.3 Lovastatin; 9.2.1.4.4 Rosuvastatin; 9.2.1.4.5 Fluvastatin; 9.2.1.4.6 Pravastatin; 9.2.1.4.7 Pitavastatin; 9.2.1.4.8 Others; 9.2.1.5 Vitamin K; 9.2.1.6 Supportive Medication; 9.2.1.6.1 Nutritional Supplements; 9.2.1.6.2 Antipyretics; 9.2.1.6.3 Others; 9.2.2 By Drug Type; 9.2.2.1 Generics; 9.2.2.2 Branded; 9.2.2.2.1 Eliquis; 9.2.2.2.2 Pradaxa; 9.2.2.2.3 Activase; 9.2.2.2.4 Aspirin; 9.2.2.2.5 Plavix; 9.2.2.2.6 Aggrenox; 9.2.2.2.7 Others; 9.2.3 By Route Of Administration; 9.2.3.1 Oral; 9.2.3.1.1 Tablet; 9.2.3.1.2 Capsules; 9.2.3.1.3 Others; 9.2.3.2 Parenteral; 9.2.3.2.1 Intravenous; 9.2.3.2.2 Subcutaneous; 9.2.3.3 Others; 9.2.4 By Mode Of Purchase; 9.2.4.1 Prescription; 9.2.4.2 Over The Counter (Otc); 9.2.5 By Therpay Type; 9.2.5.1 Combination Therapy; 9.2.5.2 Monotherapy; 9.3 Surgery; 9.3.1 Embolic Coils; 9.3.2 Aspiration Catheters; 9.3.3 Stent Retriever; 9.3.4 Surgical Clipping; 9.3.5 Others; 9.4 Other Therapy; 9.4.1 Physical Therapy; 9.4.2 Occupational Therapy; 9.4.3 Speech Therapy; 9.4.4 Others
10 Middle East And Africa Stroke Market, By Diagnosis: 10.1 Overview; 10.2 Imaging Test; 10.2.1 Computerized Tomography (Ct) Scan; 10.2.2 Magnetic Resonance Imaging (Mri); 10.2.3 Carotid Ultrasound; 10.2.4 Cerebral Angiogram; 10.3 Blood Test; 10.4 Echocardiogram; 10.5 Lumbar Puncture; 10.6 Others
11 Middle East And Africa Stroke Market, By Gender: 11.1 Overview; 11.2 Female; 11.3 Male
12 Middle East And Africa Stroke Market, By End User: 12.1 Overview; 12.2 Hospitals & Clinics; 12.3 Specialty Clinics; 12.4 Ambulatory Surgical Center; 12.5 Homecare; 12.6 Laboratories; 12.7 Others 13 Middle East And Africa Stroke Market, By Distribution Channel; 13.1 Overview; 13.2 Direct; 13.3 Retail; 13.4 Online
14 Middle East And Africa Stroke Market, By Region: 14.1 Middle East And Africa; 14.1.1 Saudi Arabia; 14.1.2 U.A.E.; 14.1.3 South Africa; 14.1.4 Egypt; 14.1.5 Qatar; 14.1.6 Kuwait; 14.1.7 Oman; 14.1.8 Bahrain; 14.1.9 Rest Of Middle East And Africa
15 Middle East And Africa Stroke Market, Company Landscape: 15.1 Company Share Analysis: Middle East And Africa
16 Swot Analysis
17 Company Profiles: 17.1 Bristol-myers Squibb Company; 17.1.1 Company Snapshot; 17.1.2 Revenue Analysis; 17.1.3 Company Share Analysis; 17.1.4 Product Portfolio; 17.1.5 Recent Development; 17.2 Boehringer Ingelheim International Gmbh; 17.2.1 Company Snapshot; 17.2.2 Product Portfolio; 17.2.3 Company Share Analysis; 17.2.4 Recent Development; 17.3 F. Hoffmann-la Roche Ltd; 17.3.1 Company Snapshot; 17.3.2 Revenue Analysis; 17.3.3 Company Share Analysis; 17.3.4 Product Portfolio
List Of Tables: Table 1 Middle East And Africa Stroke Market, By Type, 2022-2030 (Usd Thousand); Table 2 Middle East And Africa Ischemic Stroke In Stroke Market, By Region, 2021-2030 (Usd Thousand); Table 3 Middle East And Africa Ischemic Stroke In Stroke Market, By Type, 2021-2030 (Usd Thousand); Table 4 Middle East And Africa Hemorrhagic Stroke In Stroke Market, By Region, 2021-2030 (Usd Thousand); Table 5 Middle East And Africa Hemorrhagic Stroke In Stroke Market, By Type, 2021-2030 (Usd Thousand); Table 6 Middle East And Africa Transient Ischemic Attack (Tia) In Stroke Market, By Region, 2021-2030 (Usd Thousand); Table 7 Middle East And Africa Stroke Market, By Treatment, 2021-2030 (Usd Thousand); Table 8 Middle East And Africa Medication In Stroke Market, By Region, 2021-2030 (Usd Thousand); Table 9 Middle East And Africa Medication In Stroke Market, By Class, 2021-2030 (Usd Thousand); Table 10 Middle East And Africa Blood Pressure Medicines In Stroke Market, By Class, 2021-2030 (Usd Thousand); Table 11 Middle East And Africa Angiotensin-converting Enzyme (Ace) Inhibitors In Stroke Market, By Class, 2021-2030 (Usd Thousand); Table 12 Middle East And Africa Diuretics In Stroke Market, By Class, 2021-2030 (Usd Thousand); Table 13 Middle East And Africa Calcium Channel Blockers In Stroke Market, By Class, 2021-2030 (Usd Thousand); Table 14 Middle East And Africa Beta Blockers In Stroke Market, By Class, 2021-2030 (Usd Thousand); Table 15 Middle East And Africa Alpha Blockers In Stroke Market, By Class, 2021-2030 (Usd Thousand); Table 16 Middle East And Africa Antiplatelet Drugs In Stroke Market, By Class, 2021-2030 (Usd Thousand); Table 17 Middle East And Africa Anticoagulants In Stroke Market, By Class, 2021-2030 (Usd Thousand); Table 18 Middle East And Africa Tissue Plasminogen Activator (Tpa) In Stroke Market, By Class, 2021-2030 (Usd Thousand); Table 19 Middle East And Africa Statins In Stroke Market, By Class, 2021-2030 (Usd Thousand); Table 20 Middle East And Africa Supportive Medication In Stroke Market, By Class, 2021-2030 (Usd Thousand); Table 21 Middle East And Africa Medication In Stroke Market, By Drug Type, 2021-2030 (Usd Thousand); Table 22 Middle East And Africa Branded In Stroke Market, By Drug Type, 2021-2030 (Usd Thousand); Table 23 Middle East And Africa Medication In Stroke Market, By Route Of Administration, 2021-2030 (Usd Thousand); Table 24 Middle East And Africa Oral In Stroke Market, By Route Of Administration, 2021-2030 (Usd Thousand); Table 25 Middle East And Africa Parenteral In Stroke Market, By Route Of Administration, 2021-2030 (Usd Thousand); Table 26 Middle East And Africa Medication In Stroke Market, By Mode Of Purchase, 2021-2030 (Usd Thousand); Table 27 Middle East And Africa Medication In Stroke Market, By Therapy Type, 2021-2030 (Usd Thousand); Table 28 Middle East And Africa Surgery In Stroke Market, By Region, 2021-2030 (Usd Thousand); Table 29 Middle East And Africa Surgery In Stroke Market, By Treatment, 2021-2030 (Usd Thousand); Table 30 Middle East And Africa Other Therapy In Stroke Market, By Region, 2021-2030 (Usd Thousand); Table 31 Middle East And Africa Other Therapy In Stroke Market, By Treatment, 2021-2030 (Usd Thousand); Table 32 Middle East And Africa Stroke Market, By Diagnosis, 2021-2030 (Usd Thousand); Table 33 Middle East And Africa Imaging Test In Stroke Market, By Region, 2021-2030 (Usd Thousand); Table 34 Middle East And Africa Imaging Test In Stroke Market, By Type, 2021-2030 (Usd Thousand); Table 35 Middle East And Africa Blood Test In Stroke Market, By Region, 2021-2030 (Usd Thousand); Table 36 Middle East And Africa Echocardiogram In Stroke Market, By Region, 2021-2030 (Usd Thousand); Table 37 Middle East And Africa Lumbar Puncture In Stroke Market, By Region, 2021-2030 (Usd Thousand); Table 38 Middle East And Africa Others In Stroke Market, By Region, 2021-2030 (Usd Thousand); Table 39 Middle East And Africa Stroke Market, By Gender, 2021-2030 (Usd Thousand); Table 40 Middle East And Africa Female In Stroke Market, By Region, 2021-2030 (Usd Thousand); Table 41 Middle East And Africa Male In Stroke Market, By Region, 2021-2030 (Usd Thousand); Table 42 Middle East And Africa Stroke Market, By End User, 2021-2030 (Usd Thousand); Table 43 Middle East And Africa Hospitals & Clinics In Stroke Market, By Region, 2021-2030 (Usd Thousand); Table 44 Middle East And Africa Specialty Clinics In Stroke Market, By Region, 2021-2030 (Usd Thousand); Table 45 Middle East And Africa Ambulatory Surgical Center In Stroke Market, By Region, 2021-2030 (Usd Thousand); Table 46 Middle East And Africa Homecare In Stroke Market, By Region, 2021-2030 (Usd Thousand); Table 47 Middle East And Africa Laboratories In Stroke Market, By Region, 2021-2030 (Usd Thousand); Table 48 Middle East And Africa Others In Stroke Market, By Region, 2021-2030 (Usd Thousand); Table 49 Middle East And Africa Stroke Market, By Distribution Channel, 2021-2030 (Usd Thousand); Table 50 Middle East And Africa Direct In Stroke Market, By Region, 2021-2030 (Usd Thousand); Table 51 Middle East And Africa Retail In Stroke Market, By Region, 2021-2030 (Usd Thousand); Table 52 Middle East And Africa Online In Stroke Market, By Region, 2021-2030 (Usd Thousand); Table 53 Middle East And Africa Stroke Market, By Country, 2021-2030 (Usd Thousand); Table 54 Middle East And Africa Stroke Market, By Type, 2021-2030 (Usd Thousand); Table 55 Middle East And Africa Ischemic Stroke In Stroke Market, By Type, 2021-2030 (Usd Thousand); Table 56 Middle East And Africa Hemorrhagic Stroke In Stroke Market, By Type, 2021-2030 (Usd Thousand); Table 57 Middle East And Africa Stroke Market, By Diagnosis And Treatment, 2021-2030 (Usd Thousand); Table 58 Middle East And Africa Stroke Market, By Treatment, 2021-2030 (Usd Thousand); Table 59 Middle East And Africa Medication In Stroke Market, By Class, 2021-2030 (Usd Thousand); Table 60 Middle East And Africa Blood Pressure Medicine In Stroke Market, By Class, 2021-2030 (Usd Thousand); Table 61 Middle East And Africa Angiotensin-converting Enzyme (Ace) Inhibitors In Stroke Market, By Class, 2021-2030 (Usd Thousand); Table 62 Middle East And Africa Diuretics In Stroke Market, By Class, 2021-2030 (Usd Thousand); Table 63 Middle East And Africa Calcium Channel Blockers In Stroke Market, By Class, 2021-2030 (Usd Thousand); Table 64 Middle East And Africa Beta Blockers In Stroke Market, By Class, 2021-2030 (Usd Thousand); Table 65 Middle East And Africa Alpha-blockers In Stroke Market, By Class, 2021-2030 (Usd Thousand); Table 66 Middle East And Africa Antiplatelet Drugs In Stroke Market, By Class, 2021-2030 (Usd Thousand); Table 67 Middle East And Africa Anticoagulants In Stroke Market, By Class, 2021-2030 (Usd Thousand); Table 68 Middle East And Africa Tissue Plasminogen Activator (Tpa) In Stroke Market, By Class, 2021-2030 (Usd Thousand); Table 69 Middle East And Africa Statins In Stroke Market, By Class, 2021-2030 (Usd Thousand); Table 70 Middle East And Africa Supportive Medication In Stroke Market, By Class, 2021-2030 (Usd Thousand); Table 71 Middle East And Africa Medication In Stroke Market, By Drug Type, 2021-2030 (Usd Thousand); Table 72 Middle East And Africa Branded In Stroke Market, By Drug Type, 2021-2030 (Usd Thousand); Table 73 Middle East And Africa Medication In Stroke Market, By Route Of Administration, 2021-2030 (Usd Thousand); Table 74 Middle East And Africa Oral In Stroke Market, By Route Of Administration, 2021-2030 (Usd Thousand); Table 75 Middle East And Africa Parenteral In Stroke Market, By Route Of Administration, 2021-2030 (Usd Thousand); Table 76 Middle East And Africa Medication In Stroke Market, By Mode Of Purchase, 2021-2030 (Usd Thousand); Table 77 Middle East And Africa Medication In Stroke Market, By Therapy Type, 2021-2030 (Usd Thousand); Table 78 Middle East And Africa Surgery In Stroke Market, By Treatment, 2021-2030 (Usd Thousand); Table 79 Middle East And Africa Other Therapy In Stroke Market, By Treatment, 2021-2030 (Usd Thousand); Table 80 Middle East And Africa Stroke Market, By Diagnosis, 2021-2030 (Usd Thousand); Table 81 Middle East And Africa Imaging Test In Stroke Market, By Type, 2021-2030 (Usd Thousand); Table 82 Middle East And Africa Stroke Market, By Gender, 2021-2030 (Usd Thousand); Table 83 Middle East And Africa Stroke Market, By End User, 2021-2030 (Usd Thousand); Table 84 Middle East And Africa Stroke Market, By Distribution Channel, 2021-2030 (Usd Thousand); Table 85 Saudi Arabia Stroke Market, By Type, 2021-2030 (Usd Thousand); Table 86 Saudi Arabia Ischemic Stroke In Stroke Market, By Type, 2021-2030 (Usd Thousand); Table 87 Saudi Arabia Hemorrhagic Stroke In Stroke Market, By Type, 2021-2030 (Usd Thousand); Table 88 Saudi Arabia Stroke Market, By Diagnosis And Treatment, 2021-2030 (Usd Thousand); Table 89 Saudi Arabia Stroke Market, By Treatment, 2021-2030 (Usd Thousand); Table 90 Saudi Arabia Medication In Stroke Market, By Class, 2021-2030 (Usd Thousand); Table 91 Saudi Arabia Blood Pressure Medicine In Stroke Market, By Class, 2021-2030 (Usd Thousand); Table 92 Saudi Arabia Angiotensin-converting Enzyme (Ace) Inhibitors In Stroke Market, By Class, 2021-2030 (Usd Thousand); Table 93 Saudi Arabia Diuretics In Stroke Market, By Class, 2021-2030 (Usd Thousand); Table 94 Saudi Arabia Calcium Channel Blockers In Stroke Market, By Class, 2021-2030 (Usd Thousand); Table 95 Saudi Arabia Beta Blockers In Stroke Market, By Class, 2021-2030 (Usd Thousand); Table 96 Saudi Arabia Alpha-blockers In Stroke Market, By Class, 2021-2030 (Usd Thousand); Table 97 Saudi Arabia Antiplatelet Drugs In Stroke Market, By Class, 2021-2030 (Usd Thousand); Table 98 Saudi Arabia Anticoagulants In Stroke Market, By Class, 2021-2030 (Usd Thousand); Table 99 Saudi Arabia Tissue Plasminogen Activator (Tpa) In Stroke Market, By Class, 2021-2030 (Usd Thousand); Table 100 Saudi Arabia Statins In Stroke Market, By Class, 2021-2030 (Usd Thousand); Table 101 Saudi Arabia Supportive Medication In Stroke Market, By Class, 2021-2030 (Usd Thousand); Table 102 Saudi Arabia Medication In Stroke Market, By Drug Type, 2021-2030 (Usd Thousand); Table 103 Saudi Arabia Branded In Stroke Market, By Drug Type, 2021-2030 (Usd Thousand); Table 104 Saudi Arabia Medication In Stroke Market, By Route Of Administration, 2021-2030 (Usd Thousand); Table 105 Saudi Arabia Oral In Stroke Market, By Route Of Administration, 2021-2030 (Usd Thousand); Table 106 Saudi Arabia Parenteral In Stroke Market, By Route Of Administration, 2021-2030 (Usd Thousand); Table 107 Saudi Arabia Medication In Stroke Market, By Mode Of Purchase, 2021-2030 (Usd Thousand); Table 108 Saudi Arabia Medication In Stroke Market, By Therapy Type, 2021-2030 (Usd Thousand); Table 109 Saudi Arabia Surgery In Stroke Market, By Treatment, 2021-2030 (Usd Thousand); Table 110 Saudi Arabia Other Therapy In Stroke Market, By Treatment, 2021-2030 (Usd Thousand); Table 111 Saudi Arabia Stroke Market, By Diagnosis, 2021-2030 (Usd Thousand); Table 112 Saudi Arabia Imaging Test In Stroke Market, By Type, 2021-2030 (Usd Thousand); Table 113 Saudi Arabia Stroke Market, By Gender, 2021-2030 (Usd Thousand); Table 114 Saudi Arabia Stroke Market, By End User, 2021-2030 (Usd Thousand); Table 115 Saudi Arabia Stroke Market, By Distribution Channel, 2021-2030 (Usd Thousand); Table 116 U.A.E. Stroke Market, By Type, 2021-2030 (Usd Thousand); Table 117 U.A.E. Ischemic Stroke In Stroke Market, By Type, 2021-2030 (Usd Thousand); Table 118 U.A.E. Hemorrhagic Stroke In Stroke Market, By Type, 2021-2030 (Usd Thousand); Table 119 U.A.E. Stroke Market, By Diagnosis And Treatment, 2021-2030 (Usd Thousand); Table 120 U.A.E. Stroke Market, By Treatment, 2021-2030 (Usd Thousand); Table 121 U.A.E. Medication In Stroke Market, By Class, 2021-2030 (Usd Thousand); Table 122 U.A.E. Blood Pressure Medicine In Stroke Market, By Class, 2021-2030 (Usd Thousand); Table 123 U.A.E. Angiotensin-converting Enzyme (Ace) Inhibitors In Stroke Market, By Class, 2021-2030 (Usd Thousand); Table 124 U.A.E. Diuretics In Stroke Market, By Class, 2021-2030 (Usd Thousand); Table 125 U.A.E. Calcium Channel Blockers In Stroke Market, By Class, 2021-2030 (Usd Thousand); Table 126 U.A.E. Beta Blockers In Stroke Market, By Class, 2021-2030 (Usd Thousand); Table 127 U.A.E. Alpha-blockers In Stroke Market, By Class, 2021-2030 (Usd Thousand); Table 128 U.A.E. Antiplatelet Drugs In Stroke Market, By Class, 2021-2030 (Usd Thousand); Table 129 U.A.E. Anticoagulants In Stroke Market, By Class, 2021-2030 (Usd Thousand); Table 130 U.A.E. Tissue Plasminogen Activator (Tpa) In Stroke Market, By Class, 2021-2030 (Usd Thousand); Table 131 U.A.E. Statins In Stroke Market, By Class, 2021-2030 (Usd Thousand); Table 132 U.A.E. Supportive Medication In Stroke Market, By Class, 2021-2030 (Usd Thousand); Table 133 U.A.E. Medication In Stroke Market, By Drug Type, 2021-2030 (Usd Thousand); Table 134 U.A.E. Branded In Stroke Market, By Drug Type, 2021-2030 (Usd Thousand); Table 135 U.A.E. Medication In Stroke Market, By Route Of Administration, 2021-2030 (Usd Thousand); Table 136 U.A.E. Oral In Stroke Market, By Route Of Administration, 2021-2030 (Usd Thousand); Table 137 U.A.E. Parenteral In Stroke Market, By Route Of Administration, 2021-2030 (Usd Thousand); Table 138 U.A.E. Medication In Stroke Market, By Mode Of Purchase, 2021-2030 (Usd Thousand); Table 139 U.A.E. Medication In Stroke Market, By Therapy Type, 2021-2030 (Usd Thousand); Table 140 U.A.E. Surgery In Stroke Market, By Treatment, 2021-2030 (Usd Thousand); Table 141 U.A.E. Other Therapy In Stroke Market, By Treatment, 2021-2030 (Usd Thousand); Table 142 U.A.E. Stroke Market, By Diagnosis, 2021-2030 (Usd Thousand); Table 143 U.A.E. Imaging Test In Stroke Market, By Type, 2021-2030 (Usd Thousand); Table 144 U.A.E. Stroke Market, By Gender, 2021-2030 (Usd Thousand); Table 145 U.A.E. Stroke Market, By End User, 2021-2030 (Usd Thousand); Table 146 U.A.E. Stroke Market, By Distribution Channel, 2021-2030 (Usd Thousand); Table 147 South Africa Stroke Market, By Type, 2021-2030 (Usd Thousand); Table 148 South Africa Ischemic Stroke In Stroke Market, By Type, 2021-2030 (Usd Thousand); Table 149 South Africa Hemorrhagic Stroke In Stroke Market, By Type, 2021-2030 (Usd Thousand)
List Of Figures: Figure 1 Middle East And Africa Stroke Market: Segmentation; Figure 2 Middle East And Africa Stroke Market: Data Triangulation; Figure 3 Middle East And Africa Stroke Market: Droc Analysis; Figure 4 Middle East And Africa Stroke Market : Middle East And Africa Vs Regional Market Analysis; Figure 5 Middle East And Africa Stroke Market: Company Research Analysis; Figure 6 Middle East And Africa Stroke Market: Interview Demographics; Figure 7 Middle East And Africa Stroke Market: Dbmr Market Position Grid; Figure 8 Middle East And Africa Stroke Market: Market Application Coverage Grid; Figure 9 Middle East And Africa Stroke Market: Vendor Share Analysis; Figure 10 Middle East And Africa Stroke Market: Segmentation; Figure 11 Increasing Number Of Patients With Hypertension And Coronary Heart Disease Is Expected To Drive The Middle East And Africa Stroke Market Growth In The Forecast Period Of 2023 To 2030; Figure 12 Ischemic Stroke Segment Is Expected To Account For The Largest Share Of The Middle East And Africa Stroke Market In The Forecast Period Of 2023 & 2030; Figure 13 Drivers, Restraints, Opportunities, And Challenges Of The Middle East And Africa Stroke Market; Figure 14 Middle East And Africa Stroke Market: By Type, 2022; Figure 15 Middle East And Africa Stroke Market: By Type, 2023-2030 (Usd Thousand); Figure 16 Middle East And Africa Stroke Market: By Type, Cagr (2023-2030); Figure 17 Middle East And Africa Stroke Market: By Type, Lifeline Curve; Figure 18 Middle East And Africa Stroke Market: By Treatment, 2022; Figure 19 Middle East And Africa Stroke Market: By Treatment, 2023-2030 (Usd Million); Figure 20 Middle East And Africa Stroke Market: By Treatment, Cagr (2023-2030); Figure 21 Middle East And Africa Stroke Market: By Treatment, Lifeline Curve; Figure 22 Middle East And Africa Stroke Market: By Diagnosis, 2022; Figure 23 Middle East And Africa Stroke Market: By Diagnosis, 2023-2030 (Usd Thousand); Figure 24 Middle East And Africa Stroke Market: By Diagnosis, Cagr (2023-2030); Figure 25 Middle East And Africa Stroke Market: By Diagnosis, Lifeline Curve; Figure 26 Middle East And Africa Stroke Market: By Gender, 2022; Figure 27 Middle East And Africa Stroke Market: By Gender, 2023-2030 (Usd Thousand); Figure 28 Middle East And Africa Stroke Market: By Gender, Cagr (2023-2030); Figure 29 Middle East And Africa Stroke Market: By Gender, Lifeline Curve; Figure 30 Middle East And Africa Stroke Market: By End User, 2022; Figure 31 Middle East And Africa Stroke Market: By End User, 2023-2030 (Usd Thousand); Figure 32 Middle East And Africa Stroke Market: By End User, Cagr (2023-2030); Figure 33 Middle East And Africa Stroke Market: By End User, Lifeline Curve; Figure 34 Middle East And Africa Stroke Market: By Distribution Channel, 2022; Figure 35 Middle East And Africa Stroke Market: By Distribution Channel, 2023-2030 (Usd Thousand); Figure 36 Middle East And Africa Stroke Market: By Distribution Channel, Cagr (2023-2030); Figure 37 Middle East And Africa Stroke Market: By Distribution Channel, Lifeline Curve; Figure 38 Middle East And Africa Stroke Market: Snapshot (2022); Figure 39 Middle East And Africa Stroke Market: Company Share 2022 (%)